Literature DB >> 16808043

2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook.

Anita Hermann1, Martin Kaczocha, Dale G Deutsch.   

Abstract

Only a few studies have addressed the transport of 2-arachidonoylglycerol (2-AG), a naturally occurring agonist for cannabinoid receptors. Based upon saturation kinetics, these early reports have proposed that 2-AG enters the cell by a specific 2-AG transporter, via the putative anandamide transporter, or by simple diffusion. In this review, the uptake of 2-AG is discussed in light of the recent advances that have been made for anandamide transport, where the mechanism appears to be rate-limited diffusion through the membrane. Endocannabinoids may be a distinct class of agonists since they are hydrophobic and neutral, exhibiting similar biophysical properties to some anesthetics that freely diffuse through the membrane.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808043      PMCID: PMC3231572          DOI: 10.1007/bf02854913

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  32 in total

1.  The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.

Authors:  T Bisogno; M MacCarrone; L De Petrocellis; A Jarrahian; A Finazzi-Agrò; C Hillard; V Di Marzo
Journal:  Eur J Biochem       Date:  2001-04

2.  Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.

Authors:  T A Day; F Rakhshan; D G Deutsch; E L Barker
Journal:  Mol Pharmacol       Date:  2001-06       Impact factor: 4.436

3.  The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase.

Authors:  D G Deutsch; S T Glaser; J M Howell; J S Kunz; R A Puffenbarger; C J Hillard; N Abumrad
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

4.  Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol.

Authors:  M Beltramo; D Piomelli
Journal:  Neuroreport       Date:  2000-04-27       Impact factor: 1.837

Review 5.  Cellular accumulation of anandamide: consensus and controversy.

Authors:  Cecilia J Hillard; Abbas Jarrahian
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

6.  Binding of anandamide to bovine serum albumin.

Authors:  Inge N Bojesen; Harald S Hansen
Journal:  J Lipid Res       Date:  2003-07-01       Impact factor: 5.922

7.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

8.  Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.

Authors:  Martin Kaczocha; Anita Hermann; Sherrye T Glaser; Inge N Bojesen; Dale G Deutsch
Journal:  J Biol Chem       Date:  2006-02-06       Impact factor: 5.157

9.  Evidence against the presence of an anandamide transporter.

Authors:  Sherrye T Glaser; Nada A Abumrad; Folayan Fatade; Martin Kaczocha; Keith M Studholme; Dale G Deutsch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

10.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain.

Authors:  Tiziana Bisogno; Fiona Howell; Gareth Williams; Alberto Minassi; Maria Grazia Cascio; Alessia Ligresti; Isabel Matias; Aniello Schiano-Moriello; Praveen Paul; Emma-Jane Williams; Uma Gangadharan; Carl Hobbs; Vincenzo Di Marzo; Patrick Doherty
Journal:  J Cell Biol       Date:  2003-11-10       Impact factor: 10.539

View more
  14 in total

1.  Evidence for bidirectional endocannabinoid transport across cell membranes.

Authors:  Andrea Chicca; Janine Marazzi; Simon Nicolussi; Jürg Gertsch
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

2.  Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

Authors:  Neta Rimmerman; Heather B Bradshaw; Ewa Kozela; Rivka Levy; Ana Juknat; Zvi Vogel
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

4.  Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol.

Authors:  Maria Valeria Catani; Filomena Fezza; Samantha Baldassarri; Valeria Gasperi; Alessandra Bertoni; Nicoletta Pasquariello; Alessandro Finazzi-Agrò; Fabiola Sinigaglia; Luciana Avigliano; Mauro Maccarrone
Journal:  J Mol Med (Berl)       Date:  2008-09-27       Impact factor: 4.599

Review 5.  The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

Authors:  Christopher J Fowler
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

6.  Chronic ethanol treatment potentiates ethanol-induced increases in interstitial nucleus accumbens endocannabinoid levels in rats.

Authors:  Lily Alvarez-Jaimes; David G Stouffer; Loren H Parsons
Journal:  J Neurochem       Date:  2009-07-23       Impact factor: 5.372

7.  Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study.

Authors:  Joost Wiskerke; Cristina Irimia; Benjamin F Cravatt; Taco J De Vries; Anton N M Schoffelmeer; Tommy Pattij; Loren H Parsons
Journal:  ACS Chem Neurosci       Date:  2012-04-22       Impact factor: 4.418

Review 8.  Endocannabinoids in the retina: from marijuana to neuroprotection.

Authors:  Stephen Yazulla
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

Review 9.  Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.

Authors:  M D Jhaveri; D Richardson; V Chapman
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

10.  Role of cannabinoids in the regulation of bone remodeling.

Authors:  Aymen I Idris; Stuart H Ralston
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.